A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus-Reference-Cited by-同舟云学术

A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus

Published:1994-01 Issue:11 Volume:12 Page:1032-1040
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Sutter Gerd,Wyatt Linda S.,Foley Patricia L.,Bennink Jack R.,Moss Bernard

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference28 articles.

1. Smallpox and its Eradication;Fenner,1988

2. Virulenz und Immunogenität eines modifizierten Vaccinia-Virus (Stamm MVA);Hochstein-Mintzel;Z. Immun.-Forsch.,1972

3. Abstammung, Eigenschaften und Verwendung des attenuierten Vaccinia-Stammes MVA;Mayr;Infection,1975

4. Pockenimpfstamm MVA: Marker, genetische Struktur, Erfahrungen mit der parenteralen Schutzimpfung und Verhalten im abwehrgeschwächten Organismus;Mayr;Zentralbl. Bakt. Hyg. I. (Abt. Orig. B),1978

5. Bedeutung von Tierpocken für den Menschen nach Aufhebung der Pflichtimpfung gegen Pocken;Mayr;Berl. Münch. Tierärztl. Wochenschr.,1979

Cited by 260 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trimerized S expressed by modified vaccinia virus Ankara (MVA) confers superior protection against lethal SARS-CoV-2 challenge in mice;Journal of Virology;2024-07-23

2. Whole genome sequencing of recombinant viruses obtained from co-infection and superinfection of Vero cells with modified vaccinia virus ankara vectored influenza vaccine and a naturally occurring cowpox virus;Frontiers in Immunology;2024-04-03

3. Transgene expression knock-down in recombinant Modified Vaccinia virus Ankara vectors improves genetic stability and sustained transgene maintenance across multiple passages;Frontiers in Immunology;2024-02-06

4. A T cell-targeted multi-antigen vaccine generates robust cellular and humoral immunity against SARS-CoV-2 infection;Molecular Therapy - Methods & Clinical Development;2023-12

5. Vaccinia Virus Strain MVA Expressing a Prefusion-Stabilized SARS-CoV-2 Spike Glycoprotein Induces Robust Protection and Prevents Brain Infection in Mouse and Hamster Models;Vaccines;2023-05-21